Eurofins Scient (OTCMKTS:ERFSF) Reaches New 52-Week High – Should You Buy?

Eurofins Scient (OTCMKTS:ERFSF – Get Free Report)’s stock price reached a new 52-week high on Wednesday. The stock traded as high as $99.7980 and last traded at $99.7980, with a volume of 312 shares traded. The stock had previously closed at $98.2720.

Analyst Upgrades and Downgrades

Separately, Sanford C. Bernstein cut shares of Eurofins Scient from an “outperform” rating to a “hold” rating in a research note on Tuesday, September 29th. One equities research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold”.

Read Our Latest Analysis on Eurofins Scient

Eurofins Scient Price Performance

The company has a quick ratio of 1.07, a current ratio of 1.13 and a debt-to-equity ratio of 0.80. The company has a fifty day simple moving average of $88.00 and a 200-day simple moving average of $79.60.

About Eurofins Scient

(Get Free Report)

Eurofins Scientific SE is a Luxembourg-based international laboratory and testing services company. It provides analytical, inspection and certification services for the pharmaceutical, food, environmental, agricultural, consumer products and healthcare industries.

The company’s services include laboratory testing, product safety and quality analysis, environmental monitoring, pharmaceutical development and validation, genomic testing, clinical diagnostics, and agroscience services. Eurofins also supports companies and public-sector organizations with research, regulatory compliance and quality-control programs.

Founded in 1987 by Gilles Martin, Eurofins has expanded from its original focus on food testing into a broad network of laboratories and specialized testing businesses serving customers in Europe, North America, Asia-Pacific and other international markets.

Further Reading

Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.